Jul 16 |
Three Surprising Names That Could Be On Biogen's Buyout Shortlist
|
May 10 |
Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run
|
May 10 |
Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
|
May 10 |
Edgewise Therapeutics files mixed securities shelf
|
May 10 |
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
|
May 9 |
Edgewise Therapeutics GAAP EPS of -$0.33
|
May 9 |
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
|
May 9 |
Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
May 7 |
Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors
|
May 7 |
Edgewise Therapeutics doses first subject in HCM drug trial
|